Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health medicare Advantage Membership (Part C Individual & Group)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
1,898.00
Period ended Sep 30, 2026
Change on a year earlier
-15.5%
2,245.00 in Q3 2025
History
36 quarters
Since Q4 2017
Sources
31
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Medicare Advantage Membership (Part C Individual & Group) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,898.00 | -15.5% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 1,897.00 | -15.9% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,899.00 | -15.8% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,230.00 | +7.9% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q3 2025 | Sep 30, 2025 | 2,245.00 | +9.7% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,255.00 | +11.0% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 2,255.00 | +11.8% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 2,066.00 | +0.9% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 2,047.00 | -0.8% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,031.00 | -1.4% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 2,017.00 | -1.8% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 2,047.00 | +3.5% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,064.00 | +4.8% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,059.00 | +5.8% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,053.00 | +6.9% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,977.00 | +6.3% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,969.00 | +6.3% | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,946.00 | +6.7% | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,921.00 | +24.9% | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,859.00 | +30.2% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,853.00 | +30.9% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,824.00 | +33.5% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,538.00 | +14.7% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,428.00 | +17.6% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 1,416.00 | +17.7% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 1,366.00 | +16.8% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,341.00 | +17.2% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,214.00 | +20.7% | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
| Q3 2019 | Sep 30, 2019 | 1,203.00 | +21.3% | 8-K ER (FY2020Q3, 2020-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,170.00 | +24.9% | 8-K ER (FY2020Q2, 2020-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,144.00 | +24.9% | 8-K ER (FY2020Q1, 2020-04-29) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,006.00 | +34.9% | 8-K ER (FY2019Q4, 2020-01-29) ↗ |
| Q3 2018 | Sep 30, 2018 | 992.00 | – | 8-K ER (FY2019Q3, 2019-10-23) ↗ |
| Q2 2018 | Jun 30, 2018 | 937.00 | – | 8-K ER (FY2019Q2, 2019-07-24) ↗ |
| Q1 2018 | Mar 31, 2018 | 916.00 | – | 8-K ER (FY2019Q1, 2019-04-24) ↗ |
| Q4 2017 | Dec 31, 2017 | 746.00 | – | 8-K ER (FY2018Q4, 2019-01-30) ↗ |
Cite this data
StockData. (2026). Elevance Health Medicare Advantage Membership (Part C Individual & Group), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mm_medicare_advantage
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.